Exclusive know-how and technology license and sublicense to manufacture, sell, develop and sublicense a screening test product for detection of colorectal cancer, under the 'ColoAlert' trademark and brand name, consisting of a stool collection kit and a laboratory kit containing reagents and using polymerase chain reaction and genetic markers, to extract and analyze DNA and to detect blood in stool samples, including other fields of testing, to diagnostic laboratories and distributors.